Technical Analysis for AURA - Aura Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
Crossed Above 20 DMA | Bullish | 1.55% | |
Pocket Pivot | Bullish Swing Setup | 1.55% | |
Wide Bands | Range Expansion | 1.55% | |
Gapped Up | Strength | 1.55% | |
Up 3 Days in a Row | Strength | 1.55% | |
20 DMA Resistance | Bearish | 8.55% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 8.55% | |
Stochastic Reached Oversold | Weakness | 8.55% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 9 hours ago |
Down 1% | about 9 hours ago |
Up 2% | about 9 hours ago |
Up 1% | about 9 hours ago |
Gapped Up (Full) | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/07/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.3782 |
52 Week Low | 6.63 |
Average Volume | 175,495 |
200-Day Moving Average | 8.31 |
50-Day Moving Average | 9.51 |
20-Day Moving Average | 10.62 |
10-Day Moving Average | 10.62 |
Average True Range | 0.57 |
RSI (14) | 63.90 |
ADX | 28.04 |
+DI | 29.32 |
-DI | 15.57 |
Chandelier Exit (Long, 3 ATRs) | 10.67 |
Chandelier Exit (Short, 3 ATRs) | 9.81 |
Upper Bollinger Bands | 12.04 |
Lower Bollinger Band | 9.20 |
Percent B (%b) | 0.69 |
BandWidth | 26.69 |
MACD Line | 0.37 |
MACD Signal Line | 0.42 |
MACD Histogram | -0.05 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 11.89 | ||||
Resistance 3 (R3) | 11.85 | 11.57 | 11.77 | ||
Resistance 2 (R2) | 11.57 | 11.39 | 11.59 | 11.73 | |
Resistance 1 (R1) | 11.37 | 11.27 | 11.47 | 11.41 | 11.69 |
Pivot Point | 11.09 | 11.09 | 11.14 | 11.11 | 11.09 |
Support 1 (S1) | 10.89 | 10.91 | 10.99 | 10.93 | 10.65 |
Support 2 (S2) | 10.61 | 10.79 | 10.63 | 10.61 | |
Support 3 (S3) | 10.41 | 10.61 | 10.57 | ||
Support 4 (S4) | 10.45 |